Man Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $684K | Sell |
24,443
-60,673
| -71% | -$1.71M | ﹤0.01% | 1975 |
|
|
2026
Q1 | $2.43M | Buy |
85,116
+67,715
| +389% | +$2.31M | ﹤0.01% | 1489 |
|
|
2025
Q4 | $688K | Sell |
17,401
-42,094
| -71% | -$1.54M | ﹤0.01% | 1794 |
|
|
2025
Q3 | $2.1M | Sell |
59,495
-22,898
| -28% | -$789K | ﹤0.01% | 1403 |
|
|
2025
Q2 | $2.7M | Buy |
82,393
+22,784
| +38% | +$740K | 0.01% | 1296 |
|
|
2025
Q1 | $1.92M | Buy |
59,609
+35,241
| +145% | +$1.31M | ﹤0.01% | 1376 |
|
|
2024
Q4 | $745K | Buy |
+24,368
| New | +$784K | ﹤0.01% | 1566 |
|
|
2024
Q3 | – | Sell |
-18,570
| Closed | -$423K | – | 1963 |
|
|
2024
Q2 | $423K | Sell |
18,570
-12,692
| -41% | -$293K | ﹤0.01% | 1725 |
|
|
2024
Q1 | $951K | Buy |
+31,262
| New | +$1.05M | ﹤0.01% | 1558 |
|
|
2023
Q3 | – | Sell |
-124,973
| Closed | -$6.1M | – | 1130 |
|
|
2023
Q2 | $6.17M | Buy |
+124,973
| New | +$5.76M | 0.02% | 791 |
|
|
2023
Q1 | – | Sell |
-108,183
| Closed | -$4.49M | – | 953 |
|
|
2022
Q4 | $4.8M | Buy |
108,183
+950
| +0.9% | +$39.7K | 0.02% | 847 |
|
|
2022
Q3 | $4.19M | Buy |
+107,233
| New | +$4.91M | 0.02% | 803 |
|
|
2022
Q2 | – | Sell |
-116,253
| Closed | -$5.51M | – | 832 |
|
|
2022
Q1 | $7.63M | Sell |
116,253
-1,096
| -0.9% | -$71K | 0.03% | 719 |
|
|
2021
Q4 | $8.16M | Sell |
117,349
-16,845
| -13% | -$1.22M | 0.03% | 677 |
|
|
2021
Q3 | $9.33M | Sell |
134,194
-4,094
| -3% | -$315K | 0.03% | 595 |
|
|
2021
Q2 | $11M | Sell |
138,288
-19,608
| -12% | -$1.43M | 0.04% | 533 |
|
|
2021
Q1 | $10.3M | Sell |
157,896
-59,952
| -28% | -$3.69M | 0.05% | 413 |
|
|
2020
Q4 | $12.1M | Buy |
217,848
+14,452
| +7% | +$625K | 0.05% | 381 |
|
|
2020
Q3 | $8.12M | Buy |
203,396
+48,208
| +31% | +$2.04M | 0.03% | 566 |
|
|
2020
Q2 | $6.98M | Buy |
155,188
+137,071
| +757% | +$5.97M | 0.04% | 512 |
|
|
2020
Q1 | $609K | Sell |
18,117
-185,253
| -91% | -$6.66M | ﹤0.01% | 1236 |
|
|
2019
Q4 | $6.61M | Sell |
203,370
-125,761
| -38% | -$3.58M | 0.02% | 886 |
|
|
2019
Q3 | $8.21M | Sell |
329,131
-130,902
| -28% | -$3.74M | 0.03% | 654 |
|
|
2019
Q2 | $13.7M | Buy |
460,033
+116,421
| +34% | +$3.4M | 0.05% | 491 |
|
|
2019
Q1 | $9.21M | Buy |
343,612
+22,121
| +7% | +$672K | 0.03% | 615 |
|
|
2018
Q4 | $9.84M | Buy |
321,491
+108,089
| +51% | +$3.37M | 0.04% | 458 |
|
|
2018
Q3 | $7.47M | Buy |
213,402
+153,381
| +256% | +$4.86M | 0.03% | 772 |
|
|
2018
Q2 | $1.62M | Buy |
+60,021
| New | +$1.41M | 0.01% | 1444 |
|
Other funds holding ATRC
HRCM
NAMI
Man Group's ATRC Position: Q2 2026 in Review
Man Group reduced its AtriCure (ATRC) stake by 71% in Q2 2026, selling an estimated $1.71M and leaving 24,443 shares worth $684K. The position accounts for ﹤0.01% of the portfolio, ranked #1975.
Man Group first reported a position in ATRC in Q2 2018 and has held it in 28 quarters since. The position peaked at $13.7M in Q2 2019. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Man Group held 24,443 shares of AtriCure worth $684K as of Q2 2026.
- Man Group sold 60,673 AtriCure shares in Q2 2026, an estimated $1.71M.
- AtriCure made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1975 holding.
- Man Group first reported a position in AtriCure in Q2 2018 and has held it in 28 quarters since.
- Man Group's AtriCure position peaked at $13.7M in Q2 2019.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.